Publications of Klaus-Armin Nave

Syed, Y. A.; Zhao, C.; Mahad, D.; Möbius, W.; Altmann, F.; Foss, F.; González, G. A.; Sentürk, A.; Acker-Palmer, A.; Lubec, G. et al.; Lilley, K.; Franklin, R. J. M.; Nave, K.-A.; Kotter , M. R. N.: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination. Acta Neuropathologica 131 (2), pp. 281 - 298 (2016)

Saab, A. S.; Nave, K.-A.: A mechanism for myelin injury. Nature 529 (7587), pp. 474 - 475 (2016)

Lee, Y. i.; Li, Y.; Mikesh, M.; Smith, I.; Nave, K.-A.; Schwab, M. H.; Thompson, W. J.: Neuregulin1 displayed on motor axons regulates terminal Schwann cell-mediated synapse elimination at developing neuromuscular junctions. Proceedings of the National Academy of Sciences of the United States of America 113 (4), pp. E479 - E487 (2016)

Möbius, W.; Nave, K.-A.; Werner, H. B.: Electron microscopy of myelin: structure preservation by high-pressure freezing. Brain Research 1641, pp. 92 - 100 (2016)

Patzig, J.; Kusch, K.; Fledrich, R.; Eichel, M. A.; Lüders, K. A.; Möbius, W.; Sereda, M. W.; Nave, K.-A.; Martini, R.; Werner, H. B.: Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking. Glia 64 (1), pp. 155 - 174 (2016)

Mita, S.; Monasterio-Schrader, P. d.; Fünfschilling, U.; Kawasaki, T.; Mizuno, H.; Iwasato, T.; Nave, K.-A.; Werner, H. B.; Hirata, T.: Transcallosal projections require glycoprotein M6-dependent neurite growth and guidance. Cerebral Cortex 25 (11), pp. 4111 - 4125 (2015)

Maus, F.; Sakry, D.; Binamé, F.; Karram, K.; Rajalingam, K.; Watts, C.; Heywood, R.; Krüger, R.; Stegmüller, J.; Werner, H. B. et al.; Nave, K.-A.: The NG2 proteoglycan protects oligodendrocyte precursor cells against oxidative stress via interaction with OMI/HtrA2. PLoS One 10 (9), e0137311 (2015)

Trevisiol, A.; Nave, K.-A.: Brain energy metabolism: conserved functions of glycolytic glial cells. Cell Metabolism 22 (3), pp. 361 - 363 (2015)

Epplen, D. B.; Prukop, T.; Nientiedt, T.; Albrecht, P.; Arlt, F. A.; Stassart, R. M.; Kassmann, C. M.; Methner, A.; Nave, K.-A.; Werner, H. B. et al.; Sereda, M. W.: Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease. Annals of Clinical and Translational Neurology 2 (8), pp. 787 - 796 (2015)

Mitkovski, M.; Dahm, L.; Heinrich, R.; Monnheimer, M.; Gerhart, S.; Stegmüller, J.; Hanisch, U.-K.; Nave, K.-A.; Ehrenreich, H.: Erythropoietin dampens injury-induced microglial motility. Journal of Cerebral Blood Flow and Metabolism 35 (8), pp. 1233 - 1236 (2015)

Stassart, R. M.; Nave, K.-A.: Nerve regeneration: specific metabolic demands? Experimental Neurology 269, pp. 90 - 92 (2015)

Simons, M.; Nave, K.-A.: Oligodendrocytes: myelination and axonal support. Cold Spring Harbor Perspectives in Biology 8 (1), a020479 (2015)

Sun, Y.; Lehmbecker, A.; Kalkuhl, A.; Deschl, U.; Sun, W.; Rohn, K.; Tzvetanova, I.; Nave, K.-A.; Baumgärtner, W.; Ulrich, R.: STAT3 represents a molecular switch possibly inducing astroglial instead of oligodendroglial differentiation of oligodendroglial progenitor cells in Theiler's murine encephalomyelitis. Neuropathology and Applied Neurobiology 41 (3), pp. 347 - 370 (2015)

Bischof, M.; Weider, M.; Küspert, M.; Nave, K.-A.; Wegner, M.: Brg1-dependent chromatin remodelling is not essentially required during oligodendroglial differentiation. The Journal of Neuroscience 35 (1), pp. 21 - 35 (2015)

Dere, E.; Winkler, D.; Ritter, C.; Ronnenberg, A.; Poggi, G.; Patzig, J.; Gernert, M.; Müller, C.; Nave, K.-A.; Ehrenreich, H. et al.; Werner, H. B.: Gpm6b deficiency impairs sensorimotor gating and modulates the behavioral response to a 5-HT2A/C receptor agonist. Behavioural Brain Research 277, pp. 254 - 263 (2015)

Ott, C.; Martens, H.; Hassouna, I.; Oliveira, B.; Erck, C.; Zafeiriou, M.-P.; Peteri, U.-K.; Hesse, D.; Gerhart, S.; Altas, B. et al.; Kolbow, T.; Stadler, H.; Kawabe, H.; Zimmermann, W.-H.; Nave, K.-A.; Schulz-Schaeffer, W.; Jahn, O.; Ehrenreich, H.: Widespread expression of erythropoietin receptor in brain and its induction by injury. Molecular Medicine 21, pp. 803 - 815 (2015)

Chumakov, I.; Milet, A.; Cholet, N.; Primas, G.; Boucard, A.; Pereira, Y.; Graudens, E.; Mandel, J.; Laffaire, J.; Foucquier, J. et al.; Glibert, F.; Bertrand, V.; Nave, K.-A.; Sereda, M. W.; Vial, E.; Guedj, M.; Hajj, R.; Nabirotchkin, S.; Cohen, D.: Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases 9 (1), 201 (2014)

Gritsch, S.; Lu, J.; Thilemann, S.; Wörtge, S.; Möbius, W.; Bruttger, J.; Karram, K.; Ruhwedel, T.; Blanfeld, M.; Vardeh, D. et al.; Waisman, A.; Nave, K.-A.; Kuner, R.: Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice. Nature Communications 5, 5472 (2014)

Hirrlinger, J.; Nave, K.-A.: Adapting brain metabolism to myelination and long-range signal transduction. Glia 62 (11), pp. 1749 - 1761 (2014)

Nave, K.-A.; Werner, H. B.: Myelination of the Nervous System: Mechanisms and Functions. Annual Review of Cell and Developmental Biology 30, pp. 503 - 533 (2014)